Hologic Financial Statements From 2010 to 2024

HOLX Stock  USD 76.93  0.26  0.34%   
Hologic financial statements provide useful quarterly and yearly information to potential Hologic investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Hologic financial statements helps investors assess Hologic's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Hologic's valuation are summarized below:
Gross Profit
2.5 B
Profit Margin
0.1298
Market Capitalization
18.1 B
Enterprise Value Revenue
4.737
Revenue
B
We have found one hundred twenty available fundamental trends for Hologic, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Hologic regular market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 16.2 B in 2024. Enterprise Value is likely to rise to about 2 B in 2024

Hologic Total Revenue

4.87 Billion

Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic main balance sheet or income statement drivers, such as Depreciation And Amortization of 390.5 M, Interest Expense of 110.1 M or Total Revenue of 4.9 B, as well as many exotic indicators such as Price To Sales Ratio of 2.1, Dividend Yield of 0.0462 or PTB Ratio of 3.73. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
This module can also supplement Hologic's financial leverage analysis and stock options assessment as well as various Hologic Technical models . Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Hologic Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets11 B10.5 BB
Slightly volatile
Short and Long Term Debt Total1.8 B3.2 B3.2 B
Pretty Stable
Total Current Liabilities1.5 B1.4 B1.1 B
Slightly volatile
Total Stockholder Equity6.1 B5.8 B3.2 B
Slightly volatile
Property Plant And Equipment Net624.3 M594.5 M473 M
Slightly volatile
Cash3.3 B3.1 B1.2 B
Slightly volatile
Non Current Assets TotalB5.7 B5.5 B
Pretty Stable
Cash And Short Term Investments3.3 B3.1 B1.2 B
Slightly volatile
Net Receivables755.4 M719.4 M568.7 M
Slightly volatile
Common Stock Shares Outstanding167.9 M286.2 M247.1 M
Pretty Stable
Liabilities And Stockholders Equity11 B10.5 BB
Slightly volatile
Non Current Liabilities TotalB3.4 B3.7 B
Slightly volatile
Inventory745.8 M710.2 M420 M
Slightly volatile
Other Stockholder Equity2.5 B3.6 B4.2 B
Pretty Stable
Total Liabilities2.4 B4.7 B4.7 B
Pretty Stable
Total Current Assets5.1 B4.8 B2.4 B
Slightly volatile
Non Currrent Assets Other323.5 M308.1 M171.5 M
Slightly volatile
Other Current Assets249.8 M237.9 M157.8 M
Slightly volatile
Other Current LiabilitiesM9.4 M298.5 M
Very volatile
Accounts Payable860.8 M819.8 M271.1 M
Slightly volatile
Short Term Debt177.8 M330.1 M326.8 M
Very volatile
Property Plant And Equipment Gross1.6 B1.5 B755.8 M
Slightly volatile
Common Stock2.1 M3.5 M2.7 M
Slightly volatile
Other Assets216.1 M205.8 M152.9 M
Slightly volatile
Long Term Debt2.2 B2.9 B2.9 B
Pretty Stable
Common Stock Total Equity2.8 M3.5 M2.8 M
Slightly volatile
Intangible Assets1.8 BB2.1 B
Slightly volatile
Property Plant Equipment337.5 M666.7 M466.9 M
Slightly volatile
Current Deferred Revenue128 M229.1 M159.8 M
Slightly volatile
Good Will2.3 B3.8 B2.8 B
Slightly volatile
Other Liabilities441.1 M369.7 M520.1 M
Very volatile
Long Term Debt Total3.2 B3.2 B3.1 B
Slightly volatile
Capital Surpluse6.1 B6.9 B5.8 B
Slightly volatile
Deferred Long Term Liabilities85.7 M90.2 M696.6 M
Slightly volatile
Non Current Liabilities Other209.7 M418.3 M220.5 M
Slightly volatile
Short and Long Term Debt301.1 M258.3 M311.1 M
Very volatile
Long Term Investments12.8 M13.9 M19.7 M
Slightly volatile
Capital Lease Obligations65.9 M98.8 M48 M
Slightly volatile
Net Invested Capital4.6 B2.5 B5.6 B
Slightly volatile
Capital Stock3.2 M3.5 MM
Slightly volatile

Hologic Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization390.5 M371.9 M334.2 M
Slightly volatile
Interest Expense110.1 M127.8 M140 M
Pretty Stable
Total Revenue4.9 B4.6 B3.3 B
Slightly volatile
Gross Profit2.5 B2.4 B1.8 B
Slightly volatile
Other Operating Expenses3.9 B3.8 B2.6 B
Slightly volatile
EBIT1.1 BB751.6 M
Slightly volatile
EBITDA1.5 B1.4 B1.1 B
Slightly volatile
Cost Of Revenue2.4 B2.3 B1.5 B
Slightly volatile
Total Operating Expenses1.6 B1.5 B1.1 B
Slightly volatile
Research Development355.4 M338.4 M229.1 M
Slightly volatile
Selling General Administrative473.8 M451.3 M320.3 M
Slightly volatile
Selling And Marketing Expenses362.7 M684.5 M448.7 M
Slightly volatile
Interest Income113.9 M108.5 M93.2 M
Slightly volatile
Reconciled Depreciation334.7 M291.1 M416.7 M
Slightly volatile

Hologic Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow2.8 B2.7 BB
Slightly volatile
Depreciation213.9 M371.9 M390.5 M
Very volatile
Capital Expenditures181.4 M172.7 M114.6 M
Slightly volatile
End Period Cash Flow3.3 B3.2 B1.2 B
Slightly volatile
Stock Based Compensation48.4 M91.5 M59.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.13.823.5156
Slightly volatile
Dividend Yield0.04620.0440.0213
Slightly volatile
PTB Ratio3.733.934.0661
Slightly volatile
Days Sales Outstanding92.1465.1556.8888
Very volatile
Book Value Per Share19.2118.314.329
Slightly volatile
Free Cash Flow Yield0.04970.04730.0839
Pretty Stable
Invested Capital0.540.510.8965
Slightly volatile
Operating Cash Flow Per Share4.033.835.1594
Slightly volatile
Stock Based Compensation To Revenue0.01360.01780.0183
Slightly volatile
PB Ratio3.733.934.0661
Slightly volatile
EV To Sales2.323.853.8764
Slightly volatile
Free Cash Flow Per Share3.453.294.7187
Slightly volatile
ROIC0.07540.06620.1178
Very volatile
Inventory Turnover2.882.853.5917
Slightly volatile
Net Income Per Share1.751.662.8366
Slightly volatile
Days Of Inventory On Hand118132106
Slightly volatile
Payables Turnover2.352.477.7977
Slightly volatile
Sales General And Administrative To Revenue0.110.09740.0921
Slightly volatile
Research And Ddevelopement To Revenue0.0890.0840.0713
Very volatile
Cash Per Share10.499.996.6175
Slightly volatile
POCF Ratio13.9314.6612.2647
Slightly volatile
Interest Coverage5.695.419.4348
Slightly volatile
Payout Ratio0.630.60.4628
Slightly volatile
PFCF Ratio17.9617.1114.083
Slightly volatile
Days Payables Outstanding12612057.6791
Slightly volatile
Income Quality1.992.652.014
Very volatile
ROE0.08590.08180.1842
Very volatile
EV To Operating Cash Flow14.0114.7413.3856
Slightly volatile
PE Ratio47.343.1926.9758
Very volatile
Return On Tangible Assets0.08670.08260.1977
Very volatile
EV To Free Cash Flow18.0617.215.3462
Slightly volatile
Earnings Yield0.02520.0240.0498
Pretty Stable
Intangibles To Total Assets0.420.410.5358
Pretty Stable
Current Ratio3.223.993.101
Slightly volatile
Receivables Turnover3.95.86.6702
Very volatile
Graham Number27.4726.1729.5614
Slightly volatile
Shareholders Equity Per Share19.2118.314.329
Slightly volatile
Debt To Equity0.540.510.8965
Slightly volatile
Revenue Per Share15.4314.714.4244
Slightly volatile
Interest Debt Per Share11.2210.6811.5023
Very volatile
Debt To Assets0.190.280.3469
Slightly volatile
Enterprise Value Over EBITDA9.7212.8811.5837
Slightly volatile
Short Term Coverage Ratios3.133.358.4609
Pretty Stable
Price Earnings Ratio47.343.1926.9758
Very volatile
Operating Cycle210197163
Slightly volatile
Price Book Value Ratio3.733.934.0661
Slightly volatile
Days Of Payables Outstanding12612057.6791
Slightly volatile
Dividend Payout Ratio0.630.60.4628
Slightly volatile
Price To Operating Cash Flows Ratio13.9314.6612.2647
Slightly volatile
Price To Free Cash Flows Ratio17.9617.1114.083
Slightly volatile
Pretax Profit Margin0.160.150.2194
Slightly volatile
Ebt Per Ebit0.921.160.9166
Slightly volatile
Operating Profit Margin0.160.150.2388
Pretty Stable
Effective Tax Rate0.30.370.2186
Slightly volatile
Company Equity Multiplier1.621.642.3068
Slightly volatile
Long Term Debt To Capitalization0.30.33530.4267
Slightly volatile
Total Debt To Capitalization0.260.320.4363
Slightly volatile
Return On Capital Employed0.07770.09690.1363
Pretty Stable
Debt Equity Ratio0.540.510.8965
Slightly volatile
Ebit Per Revenue0.160.150.2388
Pretty Stable
Quick Ratio2.453.22.3945
Slightly volatile
Net Income Per E B T0.580.610.772
Slightly volatile
Cash Ratio2.722.591.8305
Slightly volatile
Cash Conversion Cycle42.544.7399.8962
Slightly volatile
Operating Cash Flow Sales Ratio0.250.230.3272
Pretty Stable
Days Of Inventory Outstanding118132106
Slightly volatile
Days Of Sales Outstanding92.1465.1556.8888
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.550.990.8826
Pretty Stable
Cash Flow Coverage Ratios0.410.430.4791
Slightly volatile
Price To Book Ratio3.733.934.0661
Slightly volatile
Fixed Asset Turnover10.588.978.4892
Slightly volatile
Price Cash Flow Ratio13.9314.6612.2647
Slightly volatile
Enterprise Value Multiple9.7212.8811.5837
Slightly volatile
Debt Ratio0.190.280.3469
Slightly volatile
Cash Flow To Debt Ratio0.410.430.4791
Slightly volatile
Price Sales Ratio2.13.823.5156
Slightly volatile
Return On Assets0.03370.05740.0886
Pretty Stable
Asset Turnover0.760.510.5261
Very volatile
Net Profit Margin0.110.10.1741
Pretty Stable
Gross Profit Margin0.390.460.5476
Very volatile
Price Fair Value3.733.934.0661
Slightly volatile
Return On Equity0.08590.08180.1842
Very volatile

Hologic Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap16.2 B15.4 B15.7 B
Slightly volatile
Enterprise ValueB1.9 B12.2 B
Slightly volatile

Hologic Fundamental Market Drivers

Forward Price Earnings19.1205
Cash And Short Term Investments2.7 B

Hologic Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Hologic Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Hologic income statement, its balance sheet, and the statement of cash flows. Hologic investors use historical funamental indicators, such as Hologic's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hologic investors may use each financial statement separately, they are all related. The changes in Hologic's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hologic's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hologic Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue229.1 M128 M
Total Revenue4.6 B4.9 B
Cost Of Revenue2.3 B2.4 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.1  0.11 
Research And Ddevelopement To Revenue 0.08  0.09 
Capex To Revenue(0.03)(0.04)
Revenue Per Share 14.70  15.43 
Ebit Per Revenue 0.15  0.16 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Hologic Stock analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stocks Directory
Find actively traded stocks across global markets
CEOs Directory
Screen CEOs from public companies around the world
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.373
Earnings Share
2.11
Revenue Per Share
16.228
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0649
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.